Name: Global Molecular Diagnostics Cancer Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 5.0 (243 reviews)

Global Molecular Diagnostics Cancer Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Extent Research published the latest report on global Molecular Diagnostics Cancer Market that provides a complete survey of the company profiles, the product outline, important raw material, production size, and the economic structure of the industry. Likewise, all the strengths, weakness, and opportunities of the market are provided in the report after a wide-range analysis. The Molecular Diagnostics Cancer report encompasses several other market segmentation, market growth influencers, market analytics, demographic diversification, and competitive analysis of the market. The competitive landscape includes Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex, which provide details such as latest implemented strategies, product innovations, pricing analysis, supply and demand chain, and the market revenue.

Data provided by Extent Research. Source: https://www.extentresearch.com/molecular-diagnostics-cancer-market

Other factors including geographical diversification offer the details associated with the market strategies and the status of the Molecular Diagnostics Cancer industry on both the global and regional platform. The key regions evaluated to show tremendous market growth include North America, Europe, Asia Pacific, Latin America, Middle East & Africa. It is also covers information associated with the market size, volume, and revenue. All the vital market aspects covered in the report whether positive or negative will help the clients make a right decision in terms of investment. The research report also covers the details associated with the latest market trends and foreseeable business tactics.

The historical, present, and future market growth aspects provide holistic picture of the investment opportunities. Furthermore, the changing market dynamics, consumer preferences, and the latest COVID-19 crisis are predicted to be tackled by the market players in the next few months. An assortment of various market growth aspects are well explained in this global Molecular Diagnostics Cancer market report.

Segmentation of the Global Molecular Diagnostics Cancer Market:

By Product type

Pharmacogenomic Diagnosis, Liquid Biopsy, Other,

by Application

Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System, Motor System Cancer, Reproductive System Cancer, Other,

Reasons to Purchase global Molecular Diagnostics Cancer market report:

Latest growth strategies, future scope, and market valuation are well presented for the developed and emerging market players
Array of market factors including market strength, weaknesses, threats and opportunities are analyzed
Sales and revenue statistics, product portfolio, competitive landscape, and geographical distribution are covered in the report

Report Scope and Market Segmentation

ATTRIBUTES	Global Molecular Diagnostics Cancer Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Molecular Diagnostics Cancer Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Pharmacogenomic Diagnosis
        1.2.3 Liquid Biopsy
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Respiratory Cancer
        1.3.3 Cancer of Digestive System
        1.3.4 Cancer of Urinary System
        1.3.5 Cancer of Circulatory System
        1.3.6 Motor System Cancer
        1.3.7 Reproductive System Cancer
        1.3.8 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Molecular Diagnostics Cancer Market Perspective (2017-2035)
    2.2 Molecular Diagnostics Cancer Growth Trends by Region
        2.2.1 Molecular Diagnostics Cancer Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2017-2022)
        2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2035)
    2.3 Molecular Diagnostics Cancer Market Dynamics
        2.3.1 Molecular Diagnostics Cancer Industry Trends
        2.3.2 Molecular Diagnostics Cancer Market Drivers
        2.3.3 Molecular Diagnostics Cancer Market Challenges
        2.3.4 Molecular Diagnostics Cancer Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
        3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2017-2022)
        3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2017-2022)
    3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
    3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
        3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2021
    3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
    3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
    3.7 Date of Enter into Molecular Diagnostics Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Cancer Breakdown Data by Type
    4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2017-2022)
    4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2035)
5 Molecular Diagnostics Cancer Breakdown Data by Application
    5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2017-2022)
    5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Molecular Diagnostics Cancer Market Size (2017-2035)
    6.2 North America Molecular Diagnostics Cancer Market Size by Type
        6.2.1 North America Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        6.2.2 North America Molecular Diagnostics Cancer Market Size by Type (2023-2035)
        6.2.3 North America Molecular Diagnostics Cancer Market Share by Type (2017-2035)
    6.3 North America Molecular Diagnostics Cancer Market Size by Application
        6.3.1 North America Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        6.3.2 North America Molecular Diagnostics Cancer Market Size by Application (2023-2035)
        6.3.3 North America Molecular Diagnostics Cancer Market Share by Application (2017-2035)
    6.4 North America Molecular Diagnostics Cancer Market Size by Country
        6.4.1 North America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        6.4.2 North America Molecular Diagnostics Cancer Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Molecular Diagnostics Cancer Market Size (2017-2035)
    7.2 Europe Molecular Diagnostics Cancer Market Size by Type
        7.2.1 Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        7.2.2 Europe Molecular Diagnostics Cancer Market Size by Type (2023-2035)
        7.2.3 Europe Molecular Diagnostics Cancer Market Share by Type (2017-2035)
    7.3 Europe Molecular Diagnostics Cancer Market Size by Application
        7.3.1 Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        7.3.2 Europe Molecular Diagnostics Cancer Market Size by Application (2023-2035)
        7.3.3 Europe Molecular Diagnostics Cancer Market Share by Application (2017-2035)
    7.4 Europe Molecular Diagnostics Cancer Market Size by Country
        7.4.1 Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        7.4.2 Europe Molecular Diagnostics Cancer Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2017-2035)
    8.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type
        8.2.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Molecular Diagnostics Cancer Market Share by Type (2017-2035)
    8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application
        8.3.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Molecular Diagnostics Cancer Market Share by Application (2017-2035)
    8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region
        8.4.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Molecular Diagnostics Cancer Market Size (2017-2035)
    9.2 Latin America Molecular Diagnostics Cancer Market Size by Type
        9.2.1 Latin America Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        9.2.2 Latin America Molecular Diagnostics Cancer Market Size by Type (2023-2035)
        9.2.3 Latin America Molecular Diagnostics Cancer Market Share by Type (2017-2035)
    9.3 Latin America Molecular Diagnostics Cancer Market Size by Application
        9.3.1 Latin America Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        9.3.2 Latin America Molecular Diagnostics Cancer Market Size by Application (2023-2035)
        9.3.3 Latin America Molecular Diagnostics Cancer Market Share by Application (2017-2035)
    9.4 Latin America Molecular Diagnostics Cancer Market Size by Country
        9.4.1 Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        9.4.2 Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2017-2035)
    10.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type
        10.2.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Molecular Diagnostics Cancer Market Share by Type (2017-2035)
    10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application
        10.3.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Molecular Diagnostics Cancer Market Share by Application (2017-2035)
    10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country
        10.4.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Molecular Diagnostics Cancer Introduction
        11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Danaher
        11.2.1 Danaher Company Details
        11.2.2 Danaher Business Overview
        11.2.3 Danaher Molecular Diagnostics Cancer Introduction
        11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.2.5 Danaher Recent Developments
    11.3 Siemens
        11.3.1 Siemens Company Details
        11.3.2 Siemens Business Overview
        11.3.3 Siemens Molecular Diagnostics Cancer Introduction
        11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.3.5 Siemens Recent Developments
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
        11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.4.5 Abbott Laboratories Recent Developments
    11.5 ICON Plc
        11.5.1 ICON Plc Company Details
        11.5.2 ICON Plc Business Overview
        11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
        11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.5.5 ICON Plc Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
        11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 MDxHealth
        11.7.1 MDxHealth Company Details
        11.7.2 MDxHealth Business Overview
        11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
        11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.7.5 MDxHealth Recent Developments
    11.8 Invitae
        11.8.1 Invitae Company Details
        11.8.2 Invitae Business Overview
        11.8.3 Invitae Molecular Diagnostics Cancer Introduction
        11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.8.5 Invitae Recent Developments
    11.9 PlexBio
        11.9.1 PlexBio Company Details
        11.9.2 PlexBio Business Overview
        11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
        11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.9.5 PlexBio Recent Developments
    11.10 Thermo Fisher Scientific
        11.10.1 Thermo Fisher Scientific Company Details
        11.10.2 Thermo Fisher Scientific Business Overview
        11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
        11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.10.5 Thermo Fisher Scientific Recent Developments
    11.11 Guardant Health
        11.11.1 Guardant Health Company Details
        11.11.2 Guardant Health Business Overview
        11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
        11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.11.5 Guardant Health Recent Developments
    11.12 Biocartis
        11.12.1 Biocartis Company Details
        11.12.2 Biocartis Business Overview
        11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
        11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.12.5 Biocartis Recent Developments
    11.13 Bio-Techne
        11.13.1 Bio-Techne Company Details
        11.13.2 Bio-Techne Business Overview
        11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
        11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.13.5 Bio-Techne Recent Developments
    11.14 Merck
        11.14.1 Merck Company Details
        11.14.2 Merck Business Overview
        11.14.3 Merck Molecular Diagnostics Cancer Introduction
        11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.14.5 Merck Recent Developments
    11.15 Foundation Medicine
        11.15.1 Foundation Medicine Company Details
        11.15.2 Foundation Medicine Business Overview
        11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
        11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.15.5 Foundation Medicine Recent Developments
    11.16 10X Genomics
        11.16.1 10X Genomics Company Details
        11.16.2 10X Genomics Business Overview
        11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
        11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.16.5 10X Genomics Recent Developments
    11.17 Biodesix
        11.17.1 Biodesix Company Details
        11.17.2 Biodesix Business Overview
        11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
        11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.17.5 Biodesix Recent Developments
    11.18 CytoTrack
        11.18.1 CytoTrack Company Details
        11.18.2 CytoTrack Business Overview
        11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
        11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.18.5 CytoTrack Recent Developments
    11.19 GenomOncology
        11.19.1 GenomOncology Company Details
        11.19.2 GenomOncology Business Overview
        11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
        11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.19.5 GenomOncology Recent Developments
    11.20 Luminex
        11.20.1 Luminex Company Details
        11.20.2 Luminex Business Overview
        11.20.3 Luminex Molecular Diagnostics Cancer Introduction
        11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.20.5 Luminex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Molecular Diagnostics Cancer Market